Latest News

Thursday, July 30, 2015 | Acquisitions/Mergers

Brazos Private Equity Partners To Sell Vision Source To Essilor

Brazos Private Equity Partners, a Dallas-based private investment firm, announced that it has agreed to sell its portfolio company, Vision Source, to Essilor of America, a subsidiary of Paris-based Es…

Read the full story

Thursday, July 30, 2015 | Medical Studies

Chemosurgery Appears No Less Safe Than Enucleation in Advanced Eye Cancer

Ophthalmic artery chemosurgery (OAC) for advanced-stage retinoblastoma appears at least as safe as enucleation, according to New York-based researchers. "This paper reassures clinicians worldwide…

Read the full story

Thursday, July 30, 2015 | Earnings & Financials

Inotek Pharmaceuticals Announces Conversion of $21 Million Principal Amount of 5.0% Convertible Senior Notes Due 2020

Inotek Pharmaceuticals announced that $20,970,000 of its 5.0% Convertible Senior Notes due 2020 (the “2020 Notes”) maturing February 15, 2020 have been converted into shares of common stoc…

Read the full story

Thursday, July 30, 2015 | Clinical Trials, Bayer

Phase 3 Trials for Uveal Melanoma Therapy, Behçet Disease Uveitis Fail to Reach Primary Endpoints

Phase 3 clinical trials investigating potential therapies for uveal melanoma and for Behçet disease uveitis failed to reach their primary endpoints, according to information from the two drugs&…

Read the full story

Wednesday, July 29, 2015 | Product Releases

Adaptica to Launch VisionFit Wearable Adaptive Refractor at ESCRS 2015 in Barcelona

Adaptica will launch its VisionFit Wearable Adaptive Refractor at the upcoming European Society of Cataract & Refractive Surgeons (ESCRS) meeting taking place at the Fira Gran Via, Barcelona…

Read the full story

Wednesday, July 29, 2015 | Health Care

By 2024, Health Spending Will be Nearly a Fifth of the Economy

A sharp rise in prescription drug spending, driven largely by a new generation of expensive hepatitis C drugs, helped push the nation's health-care expenditures to $3.1 trillion in 2014 -- the big…

Read the full story

Wednesday, July 29, 2015 | Health Care

Cigna to Discontinue VSP Vision Care’s Integrated Primary EyeCare Program in Kentucky

In response to a new Kentucky state law (HB 465), Cigna will discontinue VSP Vision Care’s integrated Primary EyeCare Program (IPEC), effective Sept. 15, 2015. The statute, signed into law March…

Read the full story

Tuesday, July 28, 2015 | Miscellaneous, Allergan

Allergan Kicks Off Refresh America Program to Supply First Responders With Free Eye Drops

First responders often work in conditions that can take a toll on their eyes. Exposure to heat, smoke, wind and dust may cause dry eye symptoms, such as irritated and painful eyes. This is part of the…

Read the full story

Tuesday, July 28, 2015 | Medical Studies

Long-Term Study: Ophthalmology Clinic Sees EHR Productivity Gains

A 13-provider eye clinic in Asheville, North Carolina, reaped an internal return on investment of 41% from an electronic health record (EHR) over the course of a 5-year period, according to an article…

Read the full story

Tuesday, July 28, 2015 | Medical Studies

Fibrin Glue Technique Aids in Cornea Transplant in the Developing World

Eye surgeons in developing countries can use fibrin glue on the scleral rim to increase the number of donor corneas they can use for transplant, new research from India suggests. Descemet's stripp…

Read the full story

Monday, July 27, 2015 | Acquisitions/Mergers, Allergan

Teva Deal Lets Us Double Down on Brands: Allergan CEO

Allergan President and CEO Brent Saunders said Monday the sale of its generics business would allow the company to double down on its higher margin, higher growth branded drugs business. Saunders spok…

Read the full story

Monday, July 27, 2015 | Product Releases

Opternative Launches Online, Ophthalmologist-Issued Prescription Service for Glasses and Contacts

Opternative has launched the first online eye exam service, which can provide consumers with a convenient and affordable physician-issued prescription for glasses or contacts, according to a company n…

Read the full story

Monday, July 27, 2015 | Acquisitions/Mergers, Allergan

Allergan to Acquire Naurex for $560 Million

Allergan and Naurex, a clinical-stage biopharmaceutical company developing transformative therapies for challenging disorders of the central nervous system, announced that they have entered into a def…

Read the full story

Monday, July 27, 2015 | Acquisitions/Mergers, Allergan

Teva to Acquire Allergan Generics for $40.5 Billion

Teva Pharmaceutical announced that it has signed a definitive agreement with Allergan to acquire Allergan's generics business in a transaction valued at $40.5 billion, according to a company news …

Read the full story

Friday, July 24, 2015 | Miscellaneous, Eyegate Pharmaceuticals

EyeGate Pharma Receives USPTO Notice of Allowance for Proprietary Dexamethasone Phosphate Formulation

Eyegate Pharmaceuticals announced that it has received a Notice of Allowance from the US Patent and Trademark Office (USPTO) for a patent application related to its lead product candidate, EGP-437. Th…

Read the full story
Load More
 Stock Price  Change 
 Actavis $298.98  0.00% 
 Aerie Pharmaceuticals, Inc. $18.03  -3.06% 
 Akorn, Inc. $46.42  -0.04% 
 Alimera Sciences, Inc. $4.61  -1.71% 
 Avalanche Biotechnologies $14.28  -0.07% 
 Bayer $146.25  -2.08% 
 Can-Fite Biopharma $1.93  -2.53% 
 Carl Zeiss Meditec $25.12  0.36% 
 Cooper Companies, Inc. $176.79  0.21% 
 Eleven Biotherapeutics $2.75  -1.79% 
 Escalon Medical Corp. $1.46  -5.81% 
 Essilor International $127.95  -4.51% 
 Imprimis Pharmaceuticals, Inc. $7.77  -0.77% 
 InSite Vision, Inc. $0.18  -0.06% 
 IRIDEX Corporation $7.05  2.17% 
 Johnson & Johnson $99.88  0.15% 
 Luxottica Group, S.p.A. $72.21  -1.73% 
 Merck & Company, Inc. $58.75  0.36% 
 NicOx $1.83  -2.97% 
 NovaBay Pharmaceuticals, Inc. $0.58  -1.62% 
 Novartis AG Common Stock $103.21  -0.46% 
 Ocular Therapeutix $23.84  -3.68% 
 Ophthotech Corporation $66.02  -1.40% 
 QLT $3.78  -1.56% 
 Quantel $3.24  0.93% 
 Regeneron $548.45  0.40% 
 Roche $35.84  -0.69% 
 Second Sight Medical Products $14.00  0.94% 
 STAAR Surgical Company $8.96  0.73% 
 TearLab Corporation $2.34  -1.68% 
 Thrombogenics $5.39  0.00% 
 Topcon Corporation $22.55  0.00% 
 Valeant Pharmaceuticals $254.84  -0.15% 
 Xoma $0.81  -2.95%